Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.
Iriyama N, Nakayama H, Nakagawa M, Takahata A, Sato E, Takano M, Okada K, Toyama K, Hayashi T, Abe T, Tanaka K, Senpuku Y, Osada Y, Watanabe J, Yamamoto K, Sekiguchi Y, Oshikawa G, Kimura Y, Tokuhira M, Suzuki K, Kumagai T, Ikezoe T, Toyota S, Miura K, Nakazato T, Mori T.
Iriyama N, et al. Among authors: nakayama h.
Int J Hematol. 2025 Nov 9. doi: 10.1007/s12185-025-04100-2. Online ahead of print.
Int J Hematol. 2025.
PMID: 41206814